Everest Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 7 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth -119.57%
- Ebitda -64.63%
- Net Worth -256.49%
- Total Assets 2.36%
About Everest Life Sciences
Everest Life Sciences Private Limited (ELSPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 29 May 2017 (Seven years and eight months 1 days old ). Its registered office is in Hyderabad, Telangana, India.
The Corporate was formerly known as Tarini Research Center Private Limited. The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Krishna Srikakarlapudi and Srikakarlapudi Sirisha serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U51909TG2017PTC117395
- Company No.
117395
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 May 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Everest Life Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Krishna Srikakarlapudi  | Director | 29-May-2017 | Current |
| Srikakarlapudi Sirisha | Director | 29-May-2017 | Current |
Financial Performance of Everest Life Sciences.
Everest Life Sciences Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 119.57% decrease in profit. The company's net worth observed a substantial decline by a decrease of 256.49%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Everest Life Sciences?
Unlock access to Everest Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Everest Organics LimitedSrikakarlapudi Sirisha is a mutual person
Veerat Finance And Investment LimitedKrishna Srikakarlapudi is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Everest Life Sciences?
Unlock and access historical data on people associated with Everest Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Everest Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Everest Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.